On Monday shares of QUALCOMM, Inc. (NASDAQ:QCOM) closed at $70.00. Company’s sales growth for last 5 years was 20.60% and EPS growth for next 5 years is recorded as 10.50%. On March 12, Qualcomm Inc (NASDAQ:QCOM) announced that its subsidiary Qualcomm Technologies, Inc. (QTI) is introducing the DragonBoard™ 410c, a low-cost development board design based on the 64-bit capable Qualcomm® Snapdragon™ 410 processor.
RXi Pharmaceuticals Corporation (NASDAQ:RXII) in last trading activity moved up 4.35% to close at $1.20. Company weekly performance is -7.69% while its quarterly performance stands at -40.59%. RXi Pharmaceuticals Corporation (NASDAQ:RXII) is -80.10% away from its 52 week high. RXi Pharmaceuticals Corporation (NASDAQ:RXII) announced that it will report financial results for the fourth quarter and year ended December 31, 2014 on Monday, March 30, 2015after the close of the U.S. financial markets.
On last trading day CombiMatrix Corporation (NASDAQ:CBMX) remains unchanged to close at $2.00. Its volatility for the week is 8.10% while volatility for the month is 7.40%. CBMX’s sales growth for past 5 years was 25.20% and its EPS growth for past 5 years was 45.20%. CombiMatrix Corporation (NASDAQ:CBMX) monthly performance is 0.50%. On March 12, CombiMatrix Corporation (Nasdaq:CBMX) announced that the Superior Court of the State of California, County of Orange (the “Court”), has issued its final Statement of Decision (the “Statement of Decision”) in the matter of the People of the State of California and Relator Michael Strathmann (“Plaintiff”) vs. Acacia Research Corporation, CombiMatrix Corporation and Amit Kumar (“Defendants”) and has entered Judgment in Defendants’ favor, dismissing Plaintiff’s complaint with prejudice.
The firm issued an outperform rating on the stock. Newpark Resources Inc. (NYSE:NR) has 0.50% insider ownership. In last trading activity company’s stock closed at $9.12. Credit Suisse started coverage on shares of Newpark Resources (NYSE:NR) in a research report released on Thursday morning.
On last trading day Tandem Diabetes Care, Inc. (NASDAQ:TNDM) moved up 0.15% to close at $13.49. Its volatility for the week is 4.14% while volatility for the month is 4.76%. Tandem Diabetes Care, Inc. (NASDAQ:TNDM) monthly performance is 4.49%. On March 4, Tandem Diabetes Care Inc. (NASDAQ:TNDM) announced the closing of its previously announced underwritten public offering of 6,037,500 shares of common stock at a price to the public of $11.50 per share, which includes the exercise in full by the underwriters of their option to purchase up to an additional 787,500 shares. All of the shares in the offering were offered by Tandem.